Helena Berreiros-Hortala

Helena Berreiros-Hortala

Centre for Plant Biotechnology and Genomics, Pozuelo de Alarcón, Spain
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HBHelena Berreiros-Hortala
Helena Berreiros-Hortala
GVGonzalo Vilchez-Pinto
Gonzalo Vilchez-Pinto
Araceli Díaz-PeralesAraceli Díaz-Perales
Araceli Díaz-Perales
MGMaría Garrido-Arandia
María Garrido-Arandia
JTJaime Tome-Amat
Jaime Tome-Amat
Immune engineering and modulation are the basis of a novel but powerful tool to treat immune diseases using virus-like particles (VLPs). VLPs are formed by the viral capsid without genetic material making them non-infective. However, they offer a wide variety of possibilities as antigen-presenting platforms, resulting in high immunogenicity and high efficacy in immune modulation, with low allergenicity. Both animal and plant viruses are being studied for use in the treatment of food allergies. These formulations are combined with adjuvants, T-stimulatory epitopes, TLR ligands, and other immune modulators to modulate or enhance the immune response toward the presented allergen. Here, the authors present an overview of VLP production systems, their immune modulation capabilities, and the applicability of actual VLP-based formulations targeting allergic diseases.

30 September 2023 in Allergy
Verified
Journal Article
Open access
JTJaime Tome-Amat
Jaime Tome-Amat
ZGZulema Gonzalez‐Klein
Zulema Gonzalez‐Klein
DPDiego Pazos‐Castro
Diego Pazos‐Castro
JRJose Luis Resuela‐Gonzalez
Jose Luis Resuela‐Gonzalez
GVGonzalo Vilchez-Pinto
Gonzalo Vilchez-Pinto
MGMaría Garrido-Arandia
María Garrido-Arandia

13 February 2026 in Authorea
Verified
Preprint
Open access
HBHelena Berreiros-Hortala
Helena Berreiros-Hortala
MHMengzhen Hao
Mengzhen Hao
GVGonzalo Vilchez-Pinto
Gonzalo Vilchez-Pinto
LPLucía Palacio‑García
Lucía Palacio‑García
IMIrene de María‑Camacho
Irene de María‑Camacho
Araceli Díaz-PeralesAraceli Díaz-Perales
Araceli Díaz-Perales
Background: Skin barrier disruption is increasingly recognised as a critical determinant of food allergy development, yet the molecular events linking cutaneous damage to systemic sensitisation remain incompletely defined. Ara h 2, a major peanut allergen, displays unusually high allergenic potency, but the early cutaneous mechanisms that confer immunogenicity is poorly understood. Objective: To elucidate how lipid–protein interactions and epigenetic remodelling cooperate to drive epicutaneous sensitisation to Ara h 2 following skin barrier disruption. Methods: A mouse model of repeated epicutaneous exposure to recombinant Ara h 2, alone or complexed with roasted‑peanut lipids, was combined with histology, NF‑κB reporter assays, hydrophobic‑plate binding, nanoparticle‑assisted LC‑QTOF MS, isothermal titration calorimetry, molecular docking and molecular dynamics simulations. Chromatin changes were assessed by H3K4me2 ChIP‑seq on pooled skin samples. Results: Skin barrier disruption enabled Ara h 2 to induce systemic inflammation, CD45+ infiltration in multiple organs, and allergen‑specific IgG1. Ara h 2 selectively bound sphingoid‑base lipids present in roasted peanut and damaged skin, including a putative C16 1‑deoxysphinganine identified by LC‑QTOF MS. Lipid association conferred NF‑κB activation and promoted localisation of Ara h 2 to ceramide‑rich epidermal niches enriched in CD207+ cells. Repeated exposure induced promoter‑proximal H3K4me2 and H3K9me1 gains, with enrichment of pathways linked to glycosphingolipid metabolism, antigen presentation, cytokine signalling and epithelial remodelling. Conclusion: Lipid binding and epigenetic remodelling act as dual, complementary drivers of epicutaneous sensitisation to Ara h 2. These findings identify allergen–lipid interactions and chromatin‑state modulation as potential therapeutic targets to prevent or attenuate food allergy development.